Shedeho-Meket Primary Hospital, North Wollo, Ethiopia.
Arsi University College of Health Sciences, Arsi University, P. O. Box, 394, Arsi, Ethiopia.
J Med Case Rep. 2023 Jul 28;17(1):337. doi: 10.1186/s13256-023-03811-6.
Acute hypocalcemia is generally caused by a sudden drop in serum calcium ion and presents with a mild or severe form of tetany. Even though the occurrence of hypocalcemia is well documented with certain drugs such as calcium chelators, bisphosphonates, and cisplatin, it is a very unusual and poorly documented adverse event with cimetidine and nifedipine. Here, we present a case of severe hypocalcemic tetany during simultaneous administration of cimetidine and nifedipine in a hypertensive patient with dyspepsia.
A 46-year-old known human immunodeficiency virus patient from Ethiopia on antiretroviral therapy over the past 14 years presented to the emergency department with acute exacerbation of dyspepsia and hypertensive urgency. She was given intravenous cimetidine (400 mg) and oral nifedipine (30 mg) simultaneously. One hour after the administration of these two drugs, she developed severe hypocalcemic tetany with carpopedal spasm, involuntary plantar flexion, and muscle spasms. She also had severe retrosternal chest pain and shortness of breath. Her blood pressure was 160/110 mmHg during the attack and she had no skin changes, such as urticaria. She was immediately given 1 g of calcium gluconate intravenously over 30 minutes. The carpopedal spasm progressively decreased during calcium gluconate administration. An hour later, she completely regained voluntary movement of her fingers and feet. The chest pain persisted, but resolved over the next 12 hours. The patient was discharged home after 2 days of observation. This is an unusual adverse effect that needs caution during concomitant administration of these drugs.
Severe hypocalcemic tetany can occur with concomitant administration of cimetidine and nifedipine. Immediate treatment with calcium gluconate quickly reverses this adverse event. Concomitant administration of these drugs should be done with caution or be avoided if possible.
急性低钙血症通常是由于血清钙离子突然下降引起的,表现为轻度或重度抽搐。尽管某些药物(如钙螯合剂、双膦酸盐和顺铂)引起低钙血症的发生已有充分记录,但西咪替丁和硝苯地平同时使用引起低钙血症非常罕见且记录不佳。在这里,我们报告了一例同时使用西咪替丁和硝苯地平治疗消化不良的高血压患者出现严重低钙血症性抽搐的病例。
一名来自埃塞俄比亚的 46 岁已知人类免疫缺陷病毒患者,在过去 14 年中接受抗逆转录病毒治疗,因消化不良急性加重和高血压急症到急诊就诊。她同时给予静脉注射西咪替丁(400mg)和口服硝苯地平(30mg)。在给予这两种药物后 1 小时,她出现严重的低钙血症性抽搐,表现为掌弓痉挛、足跖屈、肌肉痉挛。她还出现严重的胸骨后疼痛和呼吸困难。发作时她的血压为 160/110mmHg,无皮肤改变,如荨麻疹。她立即静脉注射 1g 葡萄糖酸钙,持续 30 分钟。在给予葡萄糖酸钙期间,掌弓痉挛逐渐减轻。1 小时后,她的手指和脚完全恢复了自主运动。胸痛持续存在,但在接下来的 12 小时内缓解。患者在观察 2 天后出院。这是一种罕见的不良反应,在同时使用这些药物时需要谨慎。
同时使用西咪替丁和硝苯地平可引起严重的低钙血症性抽搐。立即给予葡萄糖酸钙治疗可迅速逆转这种不良反应。应谨慎同时使用这些药物,或在可能的情况下避免同时使用。